People: Vision Sciences Inc (VSCI.O)

VSCI.O on Consolidated Issue listed on NASDAQ Capital Market

1.01USD
20 Aug 2014
Price Change (% chg)

$0.03 (+2.61%)
Prev Close
$0.98
Open
$1.01
Day's High
$1.01
Day's Low
$1.01
Volume
5,100
Avg. Vol
32,342
52-wk High
$1.75
52-wk Low
$0.78

Search Stocks

Summary

Name Age Since Current Position

Lewis Pell

71 2013 Chairman of the Board

Howard Zauberman

61 2013 President, Chief Executive Officer, Director

Gary Siegel

56 2014 Principal Financial Officer, Principal Accounting Officer, Vice President - Finance

Mark Landman

60 2007 Vice President - Disposables Operations

Jitendra Patel

60 2000 Vice President - Industrial Division

David Anderson

61 2005 Independent Director

Katsumi Oneda

76 2005 Independent Director

Cheryl Pegus

49 2013 Independent Director

John Rydzewski

61 2009 Independent Director

Biographies

Name Description

Lewis Pell

Mr. Lewis C. Pell is Chairman of the Board of Vision Sciences Inc., since October 2005. Prior to that, Mr. Pell is a co-founder of Vision-Sciences and has been Chairman of the Board since 2005. Mr. Pell also briefly served as our Principal Executive Officer from June 2013 to August 2013. Prior to 2005, Mr. Pell served as Vice-Chairman of our Board of Directors since 1992. Mr. Pell is a founder or co-founder and chairman and director of several privately held medical device companies and is the chairman of Photomedex, Inc., a publicly-traded dermatology company. We believe Mr. Pell’s extensive experience with Vision-Sciences and other companies in the medical device industry, particularly his experience serving as a founder and a member of the board of directors of numerous medical device companies, makes him exceptionally well-suited to serve as a member of our Board.

Howard Zauberman

Mr. Howard I. Zauberman is President, Chief Executive Officer, Director of Vision Sciences, Inc. Mr. Zauberman has over 30 years of experience as a leader in the medical products industry. Prior to joining us, from 2005 to 2012, he was Vice President of Business Development at Henry Schein, Inc., a leading global healthcare distributor serving office based medical practitioners. Mr. Zauberman also served as a Special Venture Partner at Galen Partners, a healthcare growth equity and late stage venture capital firm, focused on technology enabled services, medical devices and specialty pharmaceuticals. Prior to this, Mr. Zauberman held senior management positions at ETHICON, Inc. a Johnson & Johnson company and Pfizer, Inc. Mr. Zauberman has a Masters of Engineering Management from Northwestern University, a Bachelor of Science from Columbia University in mechanical engineering and a Bachelors degree from Queens College.

Gary Siegel

Mr. Gary Siegel is Principal Financial Officer, Principal Accounting Officer, Vice President - Finance of Vision Sciences Inc. Prior to joining the Company, Mr. Siegel was Vice President of Finance at Genta Incorporated. Previous positions during his ten years at Genta included Senior Director, Financial Services and Director, Financial Services. He also served as Genta’s Principal Financial Officer and Principal Accounting Officer and Corporate Secretary. Prior to joining Genta, Mr. Siegel worked for two years at Geller & Company, a private consulting firm, where he led the management reporting for a multi-billion dollar client. He also spent 18 years at Warner-Lambert Company and Pfizer Inc., where he held positions of progressively increasing levels of responsibility including Director, Corporate Finance and Director, Financial Planning & Reporting. Mr. Siegel holds a Master of Business Administration from Carnegie-Mellon University and a Bachelor of Science in accounting from the University of Connecticut.

Mark Landman

Mr. Mark S. Landman serves as Vice President - Disposables Operations of Vision Sciences Inc. He served as Vice President of our Medical Division since July 1999. Mr. Landman joined us from Boston Scientific in January 1991 and served in a variety of roles in product development, project management, manufacturing engineering, and material control from that date to July 1999.

Jitendra Patel

Mr. Jitendra Patel serves as Vice President - Industrial Division of Vision Sciences Inc. From August 1995 to July 2000, he served as the Manager of Sales and Marketing for that division.

David Anderson

Mr. David W. Anderson is Independent Director of Vision Sciences Inc. He is currently President and CEO of Gentis, Inc. a clinical stage spinal implant company which he joined in December 2004. Mr. Anderson has been a successful serial entrepreneur in the Medical Device field for 20 years. The focus of Mr. Anderson's career has been Orthopaedics and he has been a part of the creation and growth of five Orthopaedic organizations; Osteotech (Founder and Executive Vice President) (1986 – 1989); Bionx Implants (CEO) (1994 – 1999); Replication Medical (Founder and Director) (1999 – 2004); Orteq Ltd. (Founder and Chairman) (2003 – present); and Gentis (CEO). In addition to his Orthopaedic experience, Mr. Anderson also served as CEO of the Cardiology division of Kensey Nash (1992 – 1994) and of the Disinfection division of Sterilox Technologies (2000 – 2004). Over his 20 years as a hands-on manager in start-up operations, he has raised over $200 million in capital, taken a company through the initial public offering route onto NASDAQ and has been a part of multiple merger and acquisition transactions. Mr. Anderson began his medical technology career with Schering Plough in operations and general management. He serves as a non-executive Director for PhotoMedex (Nasdaq: PHMD) and Orteq Ltd, and sits on the Advisory Boards for Mentor Tech Ventures II and the OLK Medical Fund, both early stage Medical Technology Venture Funds. Mr. Anderson has a B.S. in Chemical Engineering from Cornell University.

Katsumi Oneda

Mr. Katsumi Oneda is an Independent Director of Vision Sciences Inc. He is a co-founder of Vision-Sciences and served as Chairman of the Board of Directors from 1990 to 1991 and again from 1993 to 2005. From 1993 through 2003, he also served as our President and Chief Executive Officer. He served as Vice-Chairman of our Board from 1992 to 1993. Mr. Oneda is a director of Photomedex, Inc. and of a private company. Mr. Oneda’s decades-long experience in the field of endoscopy and device engineering, and his pivotal role in creating and furthering our technology make him well suited to continue to serve on our Board.

Cheryl Pegus

Dr. Cheryl Pegus, M.D., MPH, is appointed as Independent Director of Vision Sciences, Inc. Dr. Pegus is a Director of Glytec, a glycemic clinical software company and Strategic Advisor to HealthFleet, Inc, an online interactive prevention company. She is the 2013 President-Elect and a member of the Board of the American Heart Association (AHA) Founder’s Affiliate. Previously, she was the Chief Medical Officer for Walgreens. She has served as the General Manager and Chief Medical Officer for SymCare Personalized Health Solutions, Inc., and the Head of Clinical Products for Aetna’s Medical Products Business Unit. Dr. Pegus also served as the Medical Director for the Cardiovascular Risk Factors Group at Pfizer Pharmaceuticals. She is a Member of the Dean’s Circle at Weill Cornell Medical College. She received an M.P.H. from Columbia University School of Public Health, an M.D. from Cornell University Medical College and completed her internal medicine residency and cardiology fellowship at New York Hospital-Cornell.

John Rydzewski

Mr. John J. Rydzewski, CPA, is Independent Director of Vision Sciences Inc., since June 26, 2009. He is the Executive Chairman of Enumeral Biomedical Corp. Prior to joining Enumeral in 2011, Mr. Rydzewski was a managing director, since 2006, of Christofferson, Robb & Company LLC, a private investment firm, and was responsible for that firm's life science investments. He previously served as a vice president in the Investment and Merchant Banking Departments of Kidder, Peabody & Co. Incorporated and as a vice president in the Healthcare Investment Banking Group of Dean Witter Reynolds Inc. Prior to investment banking, he was a manager at Price, Waterhouse & Co. He serves as Co-Chairman of the Board of Advisors of RAND Health, a unit of the RAND Corporation and he is a Director of the New York State Catholic Health Plan Inc. (d/b/a Fidelis Care New York). He previously served as a Director of other public and privately-held companies including ARV Assisted Living, Inc., United Medical Corporation, Maxim Healthcare Corporation and Healthology, Inc. Mr. Rydzewski received a Master of Business Administration and a Bachelor of Science degree with Honors, from The Wharton School of the University of Pennsylvania and a C.P.A. license in Missouri.

Basic Compensation

Name Fiscal Year Total

Lewis Pell

110,814

Howard Zauberman

590,886

Gary Siegel

--

Mark Landman

170,000

Jitendra Patel

159,500

David Anderson

--

Katsumi Oneda

109,200

Cheryl Pegus

--

John Rydzewski

--
As Of 30 Mar 2013

Options Compensation

Search Stocks